Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Accounts Payables (2023 - 2025)

Upstream Bio has reported Accounts Payables over the past 3 years, most recently at $2.7 million for Q4 2025.

  • Quarterly results put Accounts Payables at $2.7 million for Q4 2025, down 32.54% from a year ago — trailing twelve months through Dec 2025 was $2.7 million (down 32.54% YoY), and the annual figure for FY2025 was $2.7 million, down 32.54%.
  • Accounts Payables for Q4 2025 was $2.7 million at Upstream Bio, down from $4.0 million in the prior quarter.
  • Over the last five years, Accounts Payables for UPB hit a ceiling of $4.9 million in Q3 2024 and a floor of $2.0 million in Q4 2023.
  • Median Accounts Payables over the past 3 years was $4.0 million (2025), compared with a mean of $3.6 million.
  • Biggest five-year swings in Accounts Payables: skyrocketed 103.07% in 2024 and later crashed 32.54% in 2025.
  • Upstream Bio's Accounts Payables stood at $2.0 million in 2023, then surged by 103.07% to $4.0 million in 2024, then tumbled by 32.54% to $2.7 million in 2025.
  • The last three reported values for Accounts Payables were $2.7 million (Q4 2025), $4.0 million (Q3 2025), and $2.6 million (Q2 2025) per Business Quant data.